Adaptive Biotechnologies Corp
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Kyle Piskel, who has been with Company for 8 years and is currently its Principal Accounting Officer will serve as the Chief Financial Officer starting on April 8, 2024.
On April 1, 2024, the Chief Financial Officer of Adaptive Biotechnologies Corporation (the “ Company ”) Tycho Peterson submitted his resignation.
Extracted from this filing and checked against the source text.
Kyle Piskel was appointed as Chief Financial Officer at Adaptive Biotechnologies Corp.
Kyle Piskel, who has been with Company for 8 years and is currently its Principal Accounting Officer will serve as the Chief Financial Officer starting on April 8, 2024.View on SEC.gov
Tycho Peterson resigned as Chief Financial Officer at Adaptive Biotechnologies Corp.
On April 1, 2024, the Chief Financial Officer of Adaptive Biotechnologies Corporation (the “ Company ”) Tycho Peterson submitted his resignation.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.